Literature DB >> 21813729

The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer.

Shelby M King1, Tyvette S Hilliard, Lucia Y Wu, Randal C Jaffe, Asgerally T Fazleabas, Joanna E Burdette.   

Abstract

Ovarian cancer is the most lethal gynecological malignancy affecting American women. Current hypotheses concerning the etiology of ovarian cancer propose that a reduction in the lifetime number of ovulations decreases ovarian cancer risk. Advanced serous carcinoma shares several biomarkers with fallopian tube epithelial cells, suggesting that some forms of ovarian carcinoma may originate in the fallopian tube. Currently, the impact of ovulation on the tubal epithelium is unknown. In CD1 mice, ovulation did not increase tubal epithelial cell (TEC) proliferation as measured by bromodeoxyuridine incorporation and proliferating cell nuclear antigen staining as compared to unstimulated animals. In superovulated mice, an increase in the number of pro-inflammatory macrophages was detected in the oviduct. Ovulation also increased levels of phospho-γH2A.X in TEC, indicating that these cells were susceptible to double-strand DNA breakage following ovulation. To determine which components of ovulation contributed to DNA damage in the fallopian tube, an immortalized baboon TEC cell line and a three-dimensional organ culture system for mouse oviduct and baboon fallopian tubes were developed. TEC did not proliferate or display increased DNA damage in response to the gonadotropins or estradiol alone in vitro. Oxidative stress generated by treatment with hydrogen peroxide or macrophage-conditioned medium increased DNA damage in TEC in culture. Ovulation may impact the fallopian tube epithelium by generating DNA damage and stimulating macrophage infiltration but does not increase proliferation through gonadotropin signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813729      PMCID: PMC3638747          DOI: 10.1530/ERC-11-0107

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  49 in total

1.  Characterization of newly established clonal oviductal cell lines and differential hormonal regulation of gene expression.

Authors:  Tomohiro Umezu; Makoto Hanazono; Shinichi Aizawa; Yasuhiro Tomooka
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Mar-Apr       Impact factor: 2.416

2.  Distribution patterns of leucocyte subpopulations expressing different cell markers in the cumulus-oocyte complexes of pregnant and pseudopregnant mice.

Authors:  Gökhan Akkoyunlu; Emin Türkay Korgun; Ciler Celik-Ozenci; Yasemin Seval; Ramazan Demir; Ismail Ustünel
Journal:  Reprod Fertil Dev       Date:  2003       Impact factor: 2.311

3.  Cytokine involvement in oocytes and early embryos.

Authors:  M Zolti; Z Ben-Rafael; R Meirom; M Shemesh; D Bider; S Mashiach; R N Apte
Journal:  Fertil Steril       Date:  1991-08       Impact factor: 7.329

Review 4.  Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells.

Authors:  D L Croteau; V A Bohr
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

Review 5.  Early de novo ovarian cancer and cancer developing in benign ovarian lesions.

Authors:  R E Scully
Journal:  Int J Gynaecol Obstet       Date:  1995-07       Impact factor: 3.561

6.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

7.  Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes.

Authors:  N Auersperg; S L Maines-Bandiera; H G Dyck; P A Kruk
Journal:  Lab Invest       Date:  1994-10       Impact factor: 5.662

8.  Electron-microscopic studies on the development and aging of the oviduct epithelium of mice.

Authors:  M Komatsu; H Fujita
Journal:  Anat Embryol (Berl)       Date:  1978-02-20

9.  Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube.

Authors:  W Zheng; M S Magid; E E Kramer; Y T Chen
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

10.  The cellular composition of the human oviduct epithelium.

Authors:  F N Critoph; K J Dennis
Journal:  Br J Obstet Gynaecol       Date:  1977-03
View more
  66 in total

Review 1.  It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.

Authors:  Ruth Perets; Ronny Drapkin
Journal:  Cancer Res       Date:  2015-12-15       Impact factor: 12.701

Review 2.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

3.  Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid.

Authors:  Pavla Brachova; Nehemiah S Alvarez; Bradley J Van Voorhis; Lane K Christenson
Journal:  Gynecol Oncol       Date:  2017-02-16       Impact factor: 5.482

Review 4.  Targeted immune therapy of ovarian cancer.

Authors:  Keith L Knutson; Lavakumar Karyampudi; Purushottam Lamichhane; Claudia Preston
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

5.  Characterization of the immune cell repertoire in the normal fallopian tube.

Authors:  Laura Ardighieri; Silvia Lonardi; Daniele Moratto; Fabio Facchetti; Ie-Ming Shih; William Vermi; Robert J Kurman
Journal:  Int J Gynecol Pathol       Date:  2014-11       Impact factor: 2.762

6.  Reversal of tubo-ovarian atypical epithelial patterns after cessation of ovarian stimulation by letrozole.

Authors:  Ahmed A M Abdel-Hamid; Yaser Mesbah; Mona F M Soliman
Journal:  Int J Exp Pathol       Date:  2016-09-01       Impact factor: 1.925

Review 7.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

Review 8.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

9.  Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.

Authors:  M A Merritt; M De Pari; A F Vitonis; L J Titus; D W Cramer; K L Terry
Journal:  Hum Reprod       Date:  2013-01-12       Impact factor: 6.918

10.  The hen as a model of ovarian cancer.

Authors:  Patricia A Johnson; James R Giles
Journal:  Nat Rev Cancer       Date:  2013-05-16       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.